Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...
The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against ...
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse events In comparison to placebo, treatment with REC-994 400 mg showed ...
Abstract: In this paper, the efficient recursive structure for computing arbitrary length M-dimensional (M-D) discrete cosine transform (DCT) is proposed. The M-D DCT are first converted into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results